Sherrif Ibrahim
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage (NCT07053852) | Sherrif Ibrahim | 2025-06-27 |
| Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1. (NCT05858229) | Sherrif Ibrahim | 2023-06-16 |
Track Sherrif Ibrahim automatically
Every clearance here is in the API, with alerts when new ones post.